Acutecare Medical Honored with '2024 InvestHorizon Healthcare VENTURE50' Award
AccuPulse
Developer of products in the field of cardiac electrophysiology
VENTURE50It is one of the most authoritative lists in China's investment industry and has now becomeChina High-Growth Enterprise Investment Trends。
On January 9, 2025, the 2024 VENTURE50 list was finally unveiled!AccuPulse, a startup specializing in electrophysiology, has stood out among numerous companies to be honored with the "2024 Investment界 Healthcare VENTURE50".This honor not only fully demonstrates AccuPulse's innovative position and broad prospects in the electrophysiology field but also represents the investment community's high recognition of the company's technical strength and commercial potential.
AccuPulse Medical will always stay true to its original mission, continuously striving to provide patients with a one-stop solution for atrial fibrillation treatment, making AF treatment simpler, more effective, and safer.
